Skip to content

Subscriptions are live.

Plans
Logo

Why is $NMRA stock down today?

Neumora Therapeutics, Inc. Common Stock · Biological Products, (No Diagnostic Substances)

Why is $NMRA down today?

The likely driver

Neumora Therapeutics, Inc.: Q2 FY2026 results, three months to Jun 30, 2026
Neumora Therapeutics, Inc.: Q2 FY2026 results, three months to Jun 30, 2026
SEC filing · Aug 14
Price
$0.48
Move today
-0.9%
Volume vs avg
0.0x
Scanner alerts today
0
Flagged in 30 days
103
Market cap
$88M
Prev close
$0.48
Avg volume
1.2M

Nothing has triggered on NMRA yet in this session. Our scanner has flagged it 103 times in the last 30 days , most recently on October 6 for big percentage moves, unusual volume, which is why this page is here. See the full NMRA page for the chart and the alert history.

Earlier scanner activity on NMRA

  • Oct 6Unusual volume (RVOL) alert
  • Oct 6Unusual volume (RVOL) alert
  • Oct 6Unusual volume (RVOL) alert
  • Oct 5Big % mover alert
  • Oct 5Unusual volume (RVOL) alert
  • Oct 5Unusual volume (RVOL) alert
  • Oct 5Unusual volume (RVOL) alert
  • Oct 5Unusual volume (RVOL) alert
  • Oct 2Unusual volume (RVOL) alert
  • Sep 30Big % mover alert
  • Sep 30Unusual volume (RVOL) alert
  • Sep 29Unusual volume (RVOL) alert

Prior sessions in the last 30 days. A name our scanner keeps flagging is behaving differently from the rest of the market, even on a quiet day.

Free alerts

Get free $NMRA alerts the moment volume spikes

Be first to know when $NMRA makes an unusual move. Create a free account to track $NMRA, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.

Real-time RVOL & momentum alerts Personal watchlist & price alerts
Sign up free with email

No card · 5 premium days · join 800+ traders

Other stocks moving today

Each opens that stock’s own why-is-it-moving page.

Move and volume are based on the latest market data and refresh live on this page. Scanner alerts are our own real-time unusual-volume signals. This is research, not investment advice.